Related Experiment Video
Updated: Jul 29, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
Sting and p53 DNA repair pathways are compromised in Alzheimer's disease
1Department of Neurology, Marshall University Joan C. Edwards School of Medicine, Huntington, WV, 25704, USA. nelsonth@marshall.edu.
Abstract:
Alzheimer's disease (AD) is the most common cause of dementia. A common finding in AD is DNA damage. Double-strand DNA breaks (DSBs) are particularly hazardous to neurons because their post-mitotic state forces neurons to rely on error-prone and potentially mutagenic mechanisms to repair DNA breaks. However, it remains unclear whether DNA damage results from increased DNA damage or failure of DNA repair. Oligomerization of the tumor suppressor protein p53 is an essential part of DSB repair, and p53 phosphorylated on S15 is an indicator of DNA damage. We report that the monomer:dimer ratio of phosphorylated (S15) p53 is increased by 2.86-fold in temporal lobes of AD patients compared to age-matched controls, indicating that p53 oligomerization is compromised in AD. In vitro oxidation of p53 with 100 nM H2O2 produced a similar shift in the monomer:dimer ratio. A COMET test showed a higher level of DNA degradation in AD consistent with double-strand DNA damage or inhibition of repair. Protein carbonylation was also elevated (190% of control), indicating elevated oxidative stress in AD patients. Levels of the DNA repair support protein 14-3-3σ, γ-H2AX, a phosphorylated histone marking double strand DNA breaks, and phosphorylated ataxia telangiectasia mutated (ATM) protein were all increased. cGAS-STING-interferon signaling was impaired in AD and was accompanied by a depletion of STING protein from Golgi and a failure to elevate interferon despite the presence of DSBs. The results suggest that oxidation of p53 by ROS could inhibit the DDR and decrease its ability to orchestrate DSB repair by altering the oligomerization state of p53. The failure of immune-stimulated DNA repair may contribute to cell loss in AD and suggests new therapeutic targets for AD.
Insights
Alzheimer's disease (AD) involves DNA damage, with compromised p53 protein oligomerization hindering double-strand DNA break (DSB) repair. Oxidative stress and impaired DNA repair pathways contribute to neuronal loss in AD.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Alzheimer's disease (AD) is the leading cause of dementia, characterized by DNA damage in neurons.
- Neurons, being post-mitotic, have limited repair mechanisms for hazardous double-strand DNA breaks (DSBs).
- The role of increased DNA damage versus impaired DNA repair in AD pathogenesis is unclear.
Purpose of the Study:
- To investigate the status of p53 oligomerization and DNA repair pathways in Alzheimer's disease.
- To determine if oxidative stress contributes to DNA damage and repair deficits in AD.
- To explore the implications of impaired DNA repair signaling in AD progression.
Main Methods:
- Analyzed p53 monomer:dimer ratio in temporal lobes of AD patients and controls.
- Utilized in vitro oxidation of p53 and COMET assay to assess DNA damage and repair.
- Measured levels of DNA repair proteins (14-3-3σ, γ-H2AX, ATM) and oxidative stress markers (protein carbonylation).
- Investigated cGAS-STING-interferon signaling pathway activation in response to DSBs.
Main Results:
- Increased monomer:dimer ratio of phosphorylated p53 in AD brains indicates compromised oligomerization.
- Elevated DNA degradation (COMET test) and protein carbonylation suggest increased oxidative stress and DNA damage/repair inhibition.
- Upregulation of DNA repair markers (γ-H2AX, ATM) and support proteins (14-3-3σ) observed.
- Impaired cGAS-STING-interferon signaling with STING depletion and lack of interferon response despite DSBs.
Conclusions:
- Oxidative stress may impair the DNA damage response (DDR) by altering p53 oligomerization, hindering DSB repair in AD.
- Failure of immune-stimulated DNA repair pathways contributes to neuronal loss in Alzheimer's disease.
- Targeting p53 oligomerization and DNA repair mechanisms presents potential therapeutic strategies for AD.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Alzheimer's Disease: Treatment